Vitenskapelig artikkel

• Bente Sandvei Skeie; Alexander R. Craven; Eli Renate Grüner et al. (2026). Phase 1 dose-escalation trial combining sulfasalazine and stereotactic radiosurgery in patients with recurrent glioblastoma. (ekstern lenke)
• Bente Sandvei Skeie; Jian Wang; Ernest Dodoo et al. (2013). Gamma knife surgery as monotherapy with clinically relevant doses prolongs survival in a Human GBM Xenograft Model. (ekstern lenke)
• Matthias Schneider; Lea Vollmer; Anna-Laura Potthoff et al. (2021). Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastoma. (ekstern lenke)
• Sidsel Marit Bragstad; Marianne Flatebø; Gerd Karin Natvig et al. (2018). Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study. (ekstern lenke)
• Bente Skeie; Geir Olve Skeie; Per Øyvind Enger et al. (2011). Gamma Knife Surgery in Brain Melanomas: Absence of Extracranial Metastases and Tumor Volume Strongest Indicators of Prolonged Survival. (ekstern lenke)
• Justyna Kmiecik; Aurélie Poli; Nicolas H.C. Brons et al. (2013). Elevated CD3(+) and CD8(+) tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level. (ekstern lenke)
• Dorota Goplen; Sébastien Bougnaud; Uros Rajcevic et al. (2010). alpha B-Crystallin Is Elevated in Highly Infiltrative Apoptosis-Resistant Glioblastoma Cells. (ekstern lenke)
• Andrea Gras Navarro; Heidi Espedal; Justin Vareecal Joseph et al. (2019). Pretreatment of glioblastoma with bortezomib potentiates natural killer cell cytotoxicity through TRAIL/DR5 mediated apoptosis and prolongs animal survival. (ekstern lenke)
• Bente Skeie; Geir Olve Skeie; Per Øyvind Enger et al. (2011). Gamma Knife Surgery of Colorectal Brain Metastases: A High Prescription Dose of 25 Gy May Improve Growth Control. (ekstern lenke)
• Lina Wik Leiss; Ercan Mutlu; Anne Margrete Øyan et al. (2017). Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts. (ekstern lenke)
• Mev Dominguez Valentin; Andrea Gras Navarro; Mohummad Aminur Rahman et al. (2016). Identification of a natural killer cell receptor allele that prolongs survival of cytomegalovirus-positive glioblastoma patients. (ekstern lenke)
• Tao Yan; Kai Ove Skaftnesmo; Lina Wik Leiss et al. (2011). Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide. (ekstern lenke)
• Xiao Liang; Tarig Al-Hadi Osman; Dipak Sapkota et al. (2014). Rapid adherence to collagen IV enriches for tumour initiating cells in oral cancer.. (ekstern lenke)
• Ning Yang; Tao Yan; Huaiyang Zhu et al. (2014). A co-culture model with brain tumor-specific bioluminescence demonstrates astrocytes-induced drug resistance in glioblastoma.. (ekstern lenke)
• Stephen B. Willingham; Jens-Peter Volkmer; Andrew J. Gentles et al. (2012). The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. (ekstern lenke)
• Linda Sleire; Bente Sandvei Skeie; Inger Anne Netland et al. (2015). Drug repurposing: Sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc<sup>-</sup>, leading to glutathione depletion. (ekstern lenke)
• Agnete Svendsen; Joost JC Verhoeff; Heike Immervoll et al. (2011). Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma. (ekstern lenke)
• Inger Anne Netland; Hilde Elise Førde-Tislevoll; Linda Sleire et al. (2016). Treatment with the PI3K inhibitor buparlisib (NVP-BKM120) suppresses the growth of established patient-derived GBM xenografts and prolongs survival in nude rats. (ekstern lenke)
• Aurélie Poli; Jian Wang; Olivia Domingues et al. (2013). Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival. (ekstern lenke)
• Cecilie Brekke; Arvid Lundervold; Per Øyvind Enger et al. (2005). NG2 expression regulates vascular morphology and function in human brain tumours. (ekstern lenke)
• Anja Torsvik; Daniel Stieber; Per Øyvind Enger et al. (2014). U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells. (ekstern lenke)
• Jian Wang; Agnete Svendsen; Justyna Kmiecik et al. (2011). Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma. (ekstern lenke)
• Martha Chekenya; Camilla Krakstad; Agnete Svendsen et al. (2008). The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. (ekstern lenke)
• Peter Csaba Huszthy; Christian Brekken; Tina Bugge Pedersen et al. (2006). Antitumor efficacy improved by local delivery of species-specific endostatin. (ekstern lenke)
• Bente Sandvei Skeie; Per Øyvind Enger; Jonathan Knisely et al. (2020). A simple score to estimate the likelihood of pseudoprogression vs. recurrence following stereotactic radiosurgery for brain metastases: The Bergen Criteria. (ekstern lenke)
• Simone P Niclou; Claude Danzeisen; Hans Petter Eikesdal et al. (2008). A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions. (ekstern lenke)
• Eskil Eskilsson; Gro Vatne Røsland; Krishna Mukharji Talasila et al. (2016). EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation. (ekstern lenke)
• Tracy-Ann Read; Tracy-Ann Read; DR Sorensen et al. (2001). Local endostatin treatment of gliomas administered by microencapsulated producer cells. (ekstern lenke)
• M Chekenya; M Chekenya; Mari H. Hjelstuen et al. (2002). NG2 proteoglycan promotes angiogenesis-dependent tumor growth in the central nervous system by sequestering angiostatin. (ekstern lenke)
• Cecilie Brekke Rygh; Jian Wang; Marte Thuen et al. (2014). Dynamic Contrast Enhanced MRI Detects Early Response to Adoptive NK Cellular Immunotherapy Targeting the NG2 Proteoglycan in a Rat Model of Glioblastoma. (ekstern lenke)
• Cecilie Brekke; Jian Wang; Marte Thuen et al. (2014). Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma. (ekstern lenke)
• Bente Skeie; Per Øyvind Enger; Jan C Brøgger et al. (2012). Gamma knife surgery versus reoperation for recurrent glioblastoma multiforme. (ekstern lenke)
• Andrea Gras Navarro; Justyna Kmiecik; Lina Wik Leiss et al. (2014). NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival. (ekstern lenke)
• Lina Leiss; Alessandro Mega; Thomas Olsson Bontell et al. (2019). Platelet‐derived growth factor receptor α/glial fibrillary acidic protein expressing peritumoral astrocytes associate with shorter median overall survival in glioblastoma patients. (ekstern lenke)
• Alessandro Mega; Mette Hartmark Nilsen; Lina Wik Leiss et al. (2019). Astrocytes enhance glioblastoma growth. (ekstern lenke)
• Huaiyang Zhu; Lina Wik Leiss; Ning Yang et al. (2017). Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy. (ekstern lenke)
• Jian Wang; Hrvoje Miletic; Per Øystein Sakariassen et al. (2009). A reproducible brain tumour model established from human glioblastoma biopsies. (ekstern lenke)
• C Brekke; Cecilie Brekke; Arvid Lundervold et al. (2006). NG2 expression regulates vascular morphology and function in human brain tumours. (ekstern lenke)
• Hege Jacobsen; Linda Sleire; Jian Wang et al. (2013). Establishment of a novel dsRed NOD/Scid mouse strain to investigate the host and tumor cell compartments. (ekstern lenke)
• Krishna Mukharji Talasila; Anke Soentgerath; Philipp Euskirchen et al. (2013). EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis. (ekstern lenke)
• Bente Sandvei Skeie; Geir Egil Eide; Marianne Flatebø et al. (2016). Quality of life is maintained using Gamma Knife radiosurgery: A prospective study of a brain metastases patient cohort. (ekstern lenke)
• Bente Sandvei Skeie; Per Øyvind Enger; Jeremy Christopher Ganz et al. (2013). Gamma knife surgery of colorectal brain metastases: a high prescription dose of 25 Gy may improve growth control. (ekstern lenke)
• Frits Alan Thorsen; Daniel Jirak; Jian Wang et al. (2008). Two distinct tumor phenotypes isolated from glioblastomas show different MRS characteristics. (ekstern lenke)
• Mohummad Aminur Rahman; Andrea Gras Navarro; Jorunn Brekke et al. (2019). Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival. (ekstern lenke)
• Lars Prestegarden; Agnete Svendsen; Jian Wang et al. (2010). Glioma cell populations grouped by different cell type markers drive brain tumor growth. (ekstern lenke)
• Per Øystein Sakariassen; Lars Prestegarden; Jian Wang et al. (2006). Angiogenesis-independent tumor growth mediated by stem-like cancer cells. (ekstern lenke)
• Frits Alan Thorsen; Per Øyvind Enger; Jian Wang et al. (2007). Human glioblastoma biopsy spheroids xenografted into the nude rat brain show growth inhibition after stereotactic radiosurgery. (ekstern lenke)
• Dorota Goplen; Jian Wang; Per Øyvind Enger et al. (2006). Protein disulfide isomerase expression is related to the invasive properties of malignant glioma. (ekstern lenke)
• Ning Yang; Bin Huang; Oleg Tsinkalovsky et al. (2014). A novel GFP nude rat model to investigate tumor-stroma interactions. (ekstern lenke)
• Eirik Sundlisæter; Jian Wang; Per Øystein Sakariassen et al. (2006). Primary glioma spheroids maintain tumourogenicity and essential phenotypic traits after cryopreservation. (ekstern lenke)
• Inger Anne Netland; Hilde Elise Førde-Tislevoll; Linda Sleire et al. (2016). Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models. (ekstern lenke)
• Mia Niklasson; Ianluca Maddalo; Zuzana Sramkova et al. (2017). Membrane-depolarizing channel blockers induce selective glioma cell death by impairing nutrient transport and unfolded protein/amino acid responses. (ekstern lenke)
• Jian Wang; Per Øystein Sakariassen; Oleg Tsinkalovsky et al. (2008). CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. (ekstern lenke)
• Ingrid Moen; Alison Charlotte Jevne; Jian Wang et al. (2012). Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation. (ekstern lenke)
• Tor-Christian Aase Johannessen; Jian Wang; Kai Ove Skaftnesmo et al. (2009). Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell-like phenotype. (ekstern lenke)
• Tatjana Wallmann; Xing-Mei Zhang; Majken Wallerius et al. (2018). Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity. (ekstern lenke)
• Per Øyvind Enger; Geir Olve Skeie; Frits Alan Thorsen et al. (2010). Gamma knife surgery of meningiomas involving the cavernous sinus: long-term follow-up of 100 patients. (ekstern lenke)
• Ernest Dodoo; Beate Huffmann; Inti Peredo et al. (2014). Increased Survival Using Delayed Gamma Knife Radiosurgery for Recurrent High-Grade Glioma: A Feasibility Study. (ekstern lenke)
• Davide Cirillo; Shahin Sarowar; Per Øyvind Enger et al. (2021). Structure–Activity Relationships Aided Design and Synthesis of xCT Antiporter Inhibitors. (ekstern lenke)
• Shahin Sarowar; Davide Cirillo; Pablo Játiva et al. (2022). The styryl benzoic acid derivative DC10 potentiates radiotherapy by targeting the xCT-glutathione axis. (ekstern lenke)

Studieprotokoll

• Bente Sandvei Skeie; Linda Sleire; Eli Renate Grüner et al. (2026). Phase I trial combining sulfasalazine and gamma knife radiosurgery for recurrent glioblastoma. (ekstern lenke)

Forelesning

• Davide Cirillo; Tom Christian Holm Adamsen; Per Øyvind Enger et al. (2018). Synthesis of targeting molecules as tracers for PET and anticancer pro-drugs: investigation of tumor drug distribution. (ekstern lenke)
• Davide Cirillo; Shahin Sarowar; Tom Christian Holm Adamsen et al. (2018). Synthesis of targeting molecules as tracers for PET and anticancer pro-drugs: investigation of tumor drug distribution. (ekstern lenke)

Konferanseforedrag

• Davide Cirillo; Tom Christian Holm Adamsen; Per Øyvind Enger et al. (2018). Synthesis of targeting molecules as tracers for PET and anticancer pro-drugs: investigation of tumor drug distribution. (ekstern lenke)
• Davide Cirillo; Tom Christian Holm Adamsen; Per Øyvind Enger et al. (2018). Synthesis of targeting molecules as tracers for PET and anticancer pro-drugs: investigation of tumor drug distribution. (ekstern lenke)
• Davide Cirillo; Shahin Sarowar; Tom Christian Holm Adamsen et al. (2019). Synthesis of targeting molecules : PET and therapeutics. (ekstern lenke)
• Sidsel Marit Bragstad; Øystein Vesterli Tveiten; MAZIAR BEHBAHANI et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
• Christian Brekken; Per Øyvind Enger; Per Øyvind Enger et al. (2002). Endostatin Gene Transduction of Glioma Cells Modifies Brain Tumor Development: Assessment by Magnetic Resonance Imaging. (ekstern lenke)
• Sidsel Marit Bragstad; Øystein Vesterli Tveiten; MAZIAR BEHBAHANI et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
• Bente Sandvei Skeie; Per Øyvind Enger; Geir Olve Skeie et al. (2001). Gamma Knife Radiosurgery of meningiomas involving the cavernous sinus. (ekstern lenke)
• Bente Sandvei Skeie; Sidsel Marit Bragstad; Dorota Katarzyna Pazdyk Goplen et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
• Bente Sandvei Skeie; Sidsel Marit Bragstad; Dorota Goplen, MD, PhD et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
• Bente Sandvei Skeie; Sidsel Marit Bragstad; Dorota Goplen, MD, PhD et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
• Bente Sandvei Skeie; Sidsel Marit Bragstad; Shahin Sarowar et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
• Bente Sandvei Skeie; Sidsel Marit Bragstad; Dorota Goplen, MD, PhD et al. (2023). NCT04205357 – a phase I trial investigating Sulfasalazine as radiosensitizer in combination with Gamma Knife Radiosurgery for recurrent Glioblastoma and a Study protocol for a multicenter phase 2/3 trial.. (ekstern lenke)
• Per Øyvind Enger; Sidsel Marit Bragstad; Jan Ingemann Heggdal et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
• Per Øyvind Enger; Sidsel Marit Bragstad; Øystein Vesterli Tveiten et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Linda Sleire; Hilde Elise Førde-Tislevoll; Inger Anne Netland et al. (2017). Drug repurposing in cancer. (ekstern lenke)
• Eirik Sundlisæter; Aly Dicko; Per Øystein Sakariassen et al. (2007). Lymphangiogenesis in colorectal cancer - Prognostic and therapeutic aspects. (ekstern lenke)
• Lars Prestegarden; Per Øyvind Enger (2010). Cancer stem cells in the central nervous system - a critical review. (ekstern lenke)

Konferanseabstrakt

• Martha Chekenya; Inger Anne Netland; Joost JC Verhoeff et al. (2010). NG2 PROMOTES RESISTANCE TO IONIZING RADIATION BY ELEVATED PEROXIREDOXIN-1 AND DNA DAMAGE RESPONSE IN GLIOBLASTOMA MULTIFORME. (ekstern lenke)
• Peter Csaba Huszthy; Jian Wang; Per Øyvind Enger et al. (2008). Human glioblastoma tissue engraftment in immunocompetent rodent hosts. (ekstern lenke)
• Hilde Elise Sundøy Førde; Inger Anne Netland; Linda Sleire et al. (2013). COMBINED ANTI-ANGIOGENIC AND ANTI-INVASIVE TREATMENT OF ORTHOTOPICALLY ENGRAFTED HUMAN GBM XENOGRAFTS. (ekstern lenke)
• Simone P Niclou; Claude Danzeisen; Nicolaas HC Brons et al. (2008). Complete separation and phenotyping of the tumor-host cellular compartments in tumor bearing nod/scid mice. (ekstern lenke)
• Eskil Eskilsson; Krishna Mukharji Talasila; Gro Vatne Røsland et al. (2013). ACTIVATION OF THE PROTOTYPICAL SFK c-Src PROMOTES ANGIOGENESIS OF HUMAN GLIOBLASTOMA. (ekstern lenke)
• Cecilie Brekke; Marte Thuen; Aurélie Poli et al. (2012). Early MRI findings of targeting the NG2 proteoglycan in GBM. (ekstern lenke)
• Hege Jacobsen; Aly Dicko; Jian Wang et al. (2011). Separate analysis of the cancer and stroma cell populations from orthotopically implanted tumor biopsies in eGFP scid mice. (ekstern lenke)
• Davide Cirillo; Shahin Sarowar; Per Øyvind Enger et al. (2021). Front Cover: Structure-Activity-Relationship-Aided Design and Synthesis of xCT Antiporter Inhibitors (ChemMedChem 17/2021). (ekstern lenke)
• Linda Sleire; Jian Wang; Jan Heggdal et al. (2010). SULFASALAZINE SENSITIZES GLIOBLASTOMA CELLS TO RADIATION TREATMENT. (ekstern lenke)
• Lina Wik Leiss; Ivana Manini; Per Øyvind Enger (2012). HYPOXIA INDUCES CELL PROLIFERATION, EXPRESSION OF ANGIOGENIC FACTORS, AND PRIMITIVE NEURONAL MARKERS IN NORMAL GLIAL CELLS. (ekstern lenke)
• Jian Wang; Hrvoje Miletic; Per Øystein Sakariassen et al. (2009). PHENOTYPIC MODULATION OF EXPERIMENTAL GLIOMAS: PROGRESSION FROM GLIOMATOSIS CEREBRI-LIKE LESIONS TO GLIOBLASTOMA. (ekstern lenke)
• Lars Prestegarden; Agnete Svendsen; Jian Wang et al. (2009). CD133-NEGATIVE GLIOMA SUBPOPULATIONS GROUPED BY DIFFERENT CELL TYPE MARKERS DISPLAY TUMORIGENICITY IN VIVO. (ekstern lenke)
• Jian Wang; Oleg Tsinkalovsky; P Zhao et al. (2009). TARGETING THE TUMOR STROMA: A NOVEL THERAPEUTIC STRATEGY BASED ON SEPARATE ANALYSIS OF THE MALIGNANT AND STROMAL CELL COMPARTMENTS IN BRAIN TUMORS. (ekstern lenke)
• Per Øyvind Enger; Per Øystein Sakariassen; Kai Ove Skaftnesmo et al. (2004). Angiogenesis-independent growth by brain tumor cells exhibiting cancer stem cell properties. (ekstern lenke)
• Jian Wang; Oleg Tsinkalovsky; Agnete Svendsen et al. (2009). Targeting the tumor stroma: a novel therapeutic strategy based on separate analysis of the malignant and stromal cell compartments in brain tumors. (ekstern lenke)
• Per Øystein Sakariassen; Lars Prestegarden; Jian Wang et al. (2004). Forced differentiation suppresses the proliferative rate of cancer cells in brain tumours. (ekstern lenke)
• Krishna Mukharji Talasila; Anke Soentgerath; Philipp Euskirchen et al. (2013). EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis. (ekstern lenke)
• Lina Wik Leiss; Christiane Gjerde; Halala Sdik Saed et al. (2013). Oct 7 IS EXPRESSED IN HUMAN GLIOMAS AND CORRELATES WITH MALIGNANCY GRADE. (ekstern lenke)
• Martha Chekenya; Jian Wang; A Poli et al. (2010). THERAPEUTIC TARGETING OF THE NG2 PROTEOGLYCAN WITH MAB 9.2.27 AND ADOPTIVELY TRANSFERRED NK CELLS LYSES HUMAN GLIOBLASTOMA MULTIFORME IN VIVO. (ekstern lenke)
• Linda Sleire; Bente Sandvei Skeie; Inger Anne Netland et al. (2013). Sulfasalazine sensitizes glioblastoma cells to radiation treatment. (ekstern lenke)
• Lars Prestegarden; Agnete Svendsen; Jian Wang et al. (2008). CD133-NEGATIVE GLIOMA SUBPOPULATIONS GROUPED BY DIFFERENT CELL TYPE MARKERS DISPLAY TUMORGENICITY IN VIVO. (ekstern lenke)
• SP Niclou; C Danzeisen; NHC Brons et al. (2008). COMPLETE SEPARATION AND PHENOTYPING OF THE TUMOR-HOST CELLULAR COMPARTMENTS IN TUMOR-BEARING NOD/SCID MICE. (ekstern lenke)
• Jian Wang; Ecran Mutlu; Anne Margrete Øyan et al. (2011). TUMOR-ASSOCIATED GLIAL CELLS PROMOTE GROWTH OF GBM XENOGRAFTS IN EGFP NOD/SCID MICE. (ekstern lenke)

Doktorgradsavhandling

• Inger Anne Netland; Per Øyvind Enger (2015). Targeting survival signalling pathways in glioblastoma. Preclinical studies of sulfasalazine, dactolisib and buparlisib. (ekstern lenke)

Masteroppgave

• Synne Marte Andersen; Per Øyvind Enger (2010). Aquaporin 1 and Aquaporin 4 in Glioblastoma Multiforme. (ekstern lenke)
• Liesbeth Kroondijk; Per Øyvind Enger (2008). Involvement of E2F5 in brain tumour progression. (ekstern lenke)
• Ercan Mutlu; Per Øyvind Enger (2015). Tumour-associated glial cells promote the Growth of GBM xenografts. (ekstern lenke)
• Per Øyvind Enger; Linda Sleire; Lina Wik Leiss (2011). Impact of hypoxia on the expression of cell line markers and behavior of cultured glioma cell lines. (ekstern lenke)
• Seyed Mohammad Lellahi; Mohummad Aminur Rahman; Per Øyvind Enger (2014). POU3f2 in human gliomas - Expression pattern and functional role. (ekstern lenke)
• Evy Marie Thorkildsen; Per Øyvind Enger; Shahin Sarowar (2019). Sulfasalazine analogues to overcome radioresistance in cancer. (ekstern lenke)
• Mireille Kayitesi Johannessen; Per Øyvind Enger (2011). Growth of glioblastoma xenografts in the brains of NOD/SCID mice following administration of a demyelinating agent. (ekstern lenke)

Vitenskapelig bokkapittel

• Lina Wik Leiss; Ercan Mutlu; Mohummad Aminur Rahman et al. (2022). Tumor–Host Interactions in Malignant Gliomas. (ekstern lenke)

Konferanseposter

• Mohummad Aminur Rahman; Lina Wik Leiss; Seyed Mohammad Lellahi et al. (2015). The transcription factor POU3F2 is expressed in human gliomas and promotes tumorigenesis in vivo. (ekstern lenke)
• Christian Brekken; Per Øyvind Enger; Per Øyvind Enger et al. (2002). Endostatin gene trandsuction of glioma cells modifies brain tumor development: Assessment by MRI. (ekstern lenke)
• Christian Brekken; Cecilie Brekke; Cecilie Brekke et al. (2003). NG2 receptor status modifies human glioblastoma development: Assessment by MRI. (ekstern lenke)
• Christian Brekken; Cecilie Brekke; Cecilie Brekke et al. (2003). Phenotyping by MRI: NG2 Receptor Status Modifies Human Glioblastoma Development. (ekstern lenke)
• Christiane Helgestad Gjerde; Ercan Mutlu; Lina Wik Leiss et al. (2015). FGFR4 is expressed in the tumor and stromal compartments of human gliomas of all grades and histologies.. (ekstern lenke)
• Mohummad Aminur Rahman; Lina Wik Leiss; Seyed Mohammad Lellahi et al. (2014). The transcription factor POU3f2 uniformly express in human gliomas and promotes tumorigenesis and overall growth rate in vivo. (ekstern lenke)
• Marte Thuen; Jien Wang; Per Øyvind Enger et al. (2011). Therapeutic Targeting of NG2 Proteoglycan with MAb & Pre-Armed NK Cells in Human GMB Evaluated with Dynamic Enhanced & Diffusion Weighted MRI in Rats. (ekstern lenke)
• Torbjørn Austveg Strømsnes; MAZIAR BEHBAHANI; Geir Olve Skeie et al. (2021). Long term results following Repeat Gamma Knife Surgery for Incompletely obliterated Arteriovenous Malformations after the first Gamma Knife treatment. (ekstern lenke)
• Tor-Christian Aase Johannessen; Jian Wang; Kai Ove Skaftnesmo et al. (2009). Highly infiltrative brain tumors show reduced chemosensitivity associated with a stem cell-like phenotype. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.